{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,9]],"date-time":"2025-02-09T05:18:07Z","timestamp":1739078287259,"version":"3.37.0"},"reference-count":26,"publisher":"SAGE Publications","issue":"3","license":[{"start":{"date-parts":[[1999,5,1]],"date-time":"1999-05-01T00:00:00Z","timestamp":925516800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Psychopharmacol"],"published-print":{"date-parts":[[1999,5]]},"abstract":"<jats:p>Previous work in our laboratory has demonstrated region-specic effects for chronic alprazolam on binding and function at the GABA<jats:sub>A<\/jats:sub>receptor. The present study evaluated regional changes in mRNA expression of several subunits of the GABA<jats:sub>A<\/jats:sub>receptor following chronic alprazolam administration that might underlie these effects. Mice received alprazolam (2 mg\/kg\/day) or vehicle via subcutaneously implanted osmotic pumps for 1, 7, 14 or 28 days. In situ hybridization histochemistry was performed on tissue sections using [<jats:sup>35<\/jats:sup>S]dATP oligonucleotide probes corresponding to the a<jats:sub>1<\/jats:sub>and g<jats:sub>2<\/jats:sub>subunits of the GABA<jats:sub>A<\/jats:sub>receptor. Specic hybridization was clearly demonstrated and a<jats:sub>1<\/jats:sub>subunit mRNA expression in frontoparietal cortex (layers IIIV) on day 1 of infusion was reduced in animals receiving alprazolam compared to vehicle. On subsequent days, there were no alterations in the levels of a<jats:sub>1<\/jats:sub>subunit mRNA in the frontoparietal cortex, hippocampus or dentate gyrus. Expression of g<jats:sub>2<\/jats:sub>subunit mRNA was increased on day 1 in the frontoparietal cortex (layer VI), hippocampus and dentate gyrus. mRNA expression was also increased in the dentate gyrus on day 28 of infusion. Comparison of the present study with the results of chronic treatment with other benzodiazepines clearly demonstrates that the pattern of mRNA subunit alterations obtained is both treatment- and region-specic. This makes a de\u00a2nitive conclusion regarding benzodiazepines and their interactions with GABA<jats:sub>A<\/jats:sub>receptors di\u00a4cult at best.<\/jats:p>","DOI":"10.1177\/026988119901300301","type":"journal-article","created":{"date-parts":[[2009,4,1]],"date-time":"2009-04-01T23:04:54Z","timestamp":1238627094000},"page":"211-218","source":"Crossref","is-referenced-by-count":6,"title":["In situ hybridization histochemistry as a method to assess GABAAreceptor subunit mRNA expression following chronic alprazolam administration"],"prefix":"10.1177","volume":"13","author":[{"given":"Jeanne M.","family":"Fahey","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gary A.","family":"Pritchard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeffrey M.","family":"Grassi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John S.","family":"Pratt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard I.","family":"Shader","sequence":"additional","affiliation":[{"name":"Department of Pharmacology and Experimental Therapeutics, Tufts University School of Medicine and the Division of Clinical Pharmacology, New England Medical Center, Boston, MA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David J.","family":"Greenblatt","sequence":"additional","affiliation":[{"name":"Department of Pharmacology and Experimental Therapeutics, Tufts University School of Medicine and the Division of Clinical Pharmacology, New England Medical Center, Boston, MA, USA;"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"179","published-online":{"date-parts":[[1999,5,1]]},"reference":[{"volume-title":"Current protocols in molecular biology","year":"1989","author":"Ausubel F M","key":"atypb1"},{"key":"atypb2","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1988.01800290027004"},{"key":"atypb3","doi-asserted-by":"publisher","DOI":"10.1002\/j.1552-4604.1986.tb03526.x"},{"key":"atypb4","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1983.03330460039029"},{"key":"atypb5","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.144.3.303"},{"key":"atypb6","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1016\/S0022-3565(25)11429-8","volume":"260","author":"Gri\u00a4ths R R","year":"1992","journal-title":"J Pharmacol Exp Ther"},{"key":"atypb7","doi-asserted-by":"publisher","DOI":"10.1007\/BF02876917"},{"key":"atypb8","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1016\/S0026-895X(25)09071-6","volume":"49","author":"Impagnatiello F","year":"1996","journal-title":"Mol Pharmacol"},{"key":"atypb9","doi-asserted-by":"publisher","DOI":"10.1111\/j.1476-5381.1991.tb09781.x"},{"key":"atypb10","doi-asserted-by":"publisher","DOI":"10.1016\/0091-3057(88)90488-1"},{"key":"atypb11","doi-asserted-by":"publisher","DOI":"10.1016\/0028-3908(90)90007-E"},{"key":"atypb12","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.ne.17.030194.003033"},{"key":"atypb13","doi-asserted-by":"publisher","DOI":"10.1016\/0304-3940(91)90687-O"},{"key":"atypb14","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-4159.1987.tb01032.x"},{"key":"atypb15","doi-asserted-by":"crossref","first-page":"3773","DOI":"10.1016\/0006-2952(89)90584-4","volume":"38","author":"Miller L G","year":"1989","journal-title":"Biochem Pharmacol"},{"key":"atypb16","doi-asserted-by":"publisher","DOI":"10.1016\/0922-4106(92)90051-V"},{"key":"atypb17","doi-asserted-by":"publisher","DOI":"10.1096\/fasebj.4.5.2155149"},{"key":"atypb18","doi-asserted-by":"publisher","DOI":"10.1016\/S0306-4522(96)00609-4"},{"key":"atypb19","doi-asserted-by":"publisher","DOI":"10.1126\/science.2551039"},{"key":"atypb20","doi-asserted-by":"publisher","DOI":"10.1038\/338582a0"},{"key":"atypb21","doi-asserted-by":"publisher","DOI":"10.1016\/S0169-328X(96)00166-0"},{"key":"atypb22","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199305133281907"},{"key":"atypb23","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0031-6997(25)06840-1","volume":"47","author":"Sieghart W","year":"1995","journal-title":"Pharmacol Rev"},{"key":"atypb24","doi-asserted-by":"publisher","DOI":"10.1007\/BF02821559"},{"key":"atypb25","doi-asserted-by":"publisher","DOI":"10.1016\/0076-6879(89)68051-2"},{"key":"atypb26","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/S0026-895X(25)10150-8","volume":"45","author":"Zhao TJ","year":"1994","journal-title":"Mol Pharmacol"}],"container-title":["Journal of Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/026988119901300301","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/026988119901300301","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,8]],"date-time":"2025-02-08T20:22:17Z","timestamp":1739046137000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/026988119901300301"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1999,5]]},"references-count":26,"journal-issue":{"issue":"3","published-print":{"date-parts":[[1999,5]]}},"alternative-id":["10.1177\/026988119901300301"],"URL":"https:\/\/doi.org\/10.1177\/026988119901300301","relation":{},"ISSN":["0269-8811","1461-7285"],"issn-type":[{"type":"print","value":"0269-8811"},{"type":"electronic","value":"1461-7285"}],"subject":[],"published":{"date-parts":[[1999,5]]}}}